nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—Leukaemia—Etidronic acid—Paget's disease of bone	0.0492	0.0504	CcSEcCtD
Pimecrolimus—Leukaemia—Alendronate—Paget's disease of bone	0.0419	0.043	CcSEcCtD
Pimecrolimus—Skin cancer—Risedronate—Paget's disease of bone	0.0292	0.0299	CcSEcCtD
Pimecrolimus—Influenza like illness—Tiludronate—Paget's disease of bone	0.0268	0.0275	CcSEcCtD
Pimecrolimus—Rhinitis—Tiludronate—Paget's disease of bone	0.0139	0.0143	CcSEcCtD
Pimecrolimus—Toothache—Zoledronate—Paget's disease of bone	0.0129	0.0133	CcSEcCtD
Pimecrolimus—Back pain—Tiludronate—Paget's disease of bone	0.0117	0.012	CcSEcCtD
Pimecrolimus—Otitis media—Risedronate—Paget's disease of bone	0.0116	0.0119	CcSEcCtD
Pimecrolimus—Influenza like illness—Alendronate—Paget's disease of bone	0.011	0.0112	CcSEcCtD
Pimecrolimus—Throat sore—Zoledronate—Paget's disease of bone	0.0109	0.0112	CcSEcCtD
Pimecrolimus—Oropharyngeal discomfort—Zoledronate—Paget's disease of bone	0.0108	0.0111	CcSEcCtD
Pimecrolimus—Rhinorrhoea—Pamidronate—Paget's disease of bone	0.0106	0.0109	CcSEcCtD
Pimecrolimus—Arthralgia—Tiludronate—Paget's disease of bone	0.0103	0.0106	CcSEcCtD
Pimecrolimus—Neoplasm malignant—Pamidronate—Paget's disease of bone	0.0101	0.0103	CcSEcCtD
Pimecrolimus—Bone disorder—Risedronate—Paget's disease of bone	0.01	0.0103	CcSEcCtD
Pimecrolimus—Herpes simplex—Pamidronate—Paget's disease of bone	0.00934	0.00958	CcSEcCtD
Pimecrolimus—Neoplasm malignant—Zoledronate—Paget's disease of bone	0.0092	0.00944	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.00899	0.00922	CcSEcCtD
Pimecrolimus—Influenza like illness—Risedronate—Paget's disease of bone	0.00879	0.00902	CcSEcCtD
Pimecrolimus—Bone disorder—Zoledronate—Paget's disease of bone	0.0087	0.00892	CcSEcCtD
Pimecrolimus—Oropharyngeal pain—Zoledronate—Paget's disease of bone	0.00864	0.00886	CcSEcCtD
Pimecrolimus—Pain—Tiludronate—Paget's disease of bone	0.00843	0.00865	CcSEcCtD
Pimecrolimus—Influenza like illness—Pamidronate—Paget's disease of bone	0.00836	0.00857	CcSEcCtD
Pimecrolimus—Asthma—Etidronic acid—Paget's disease of bone	0.00831	0.00852	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00806	0.00827	CcSEcCtD
Pimecrolimus—Abdominal pain—Tiludronate—Paget's disease of bone	0.0078	0.008	CcSEcCtD
Pimecrolimus—Influenza like illness—Zoledronate—Paget's disease of bone	0.00763	0.00783	CcSEcCtD
Pimecrolimus—Gastroenteritis—Risedronate—Paget's disease of bone	0.00741	0.0076	CcSEcCtD
Pimecrolimus—Swelling—Pamidronate—Paget's disease of bone	0.00708	0.00726	CcSEcCtD
Pimecrolimus—Asthma—Alendronate—Paget's disease of bone	0.00708	0.00726	CcSEcCtD
Pimecrolimus—Diarrhoea—Tiludronate—Paget's disease of bone	0.00675	0.00692	CcSEcCtD
Pimecrolimus—Swelling—Zoledronate—Paget's disease of bone	0.00647	0.00663	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.00646	0.00663	CcSEcCtD
Pimecrolimus—Headache—Tiludronate—Paget's disease of bone	0.00618	0.00634	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Risedronate—Paget's disease of bone	0.006	0.00615	CcSEcCtD
Pimecrolimus—Breast disorder—Risedronate—Paget's disease of bone	0.00594	0.00609	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00588	0.00603	CcSEcCtD
Pimecrolimus—Nausea—Tiludronate—Paget's disease of bone	0.00586	0.00601	CcSEcCtD
Pimecrolimus—Erythema—Etidronic acid—Paget's disease of bone	0.00579	0.00594	CcSEcCtD
Pimecrolimus—Asthma—Risedronate—Paget's disease of bone	0.00568	0.00582	CcSEcCtD
Pimecrolimus—Influenza—Risedronate—Paget's disease of bone	0.00568	0.00582	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.00559	0.00573	CcSEcCtD
Pimecrolimus—Bronchitis—Risedronate—Paget's disease of bone	0.00546	0.0056	CcSEcCtD
Pimecrolimus—Influenza—Pamidronate—Paget's disease of bone	0.0054	0.00554	CcSEcCtD
Pimecrolimus—Angioedema—Etidronic acid—Paget's disease of bone	0.00529	0.00542	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00528	0.00541	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Zoledronate—Paget's disease of bone	0.00521	0.00534	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.0051	0.00523	CcSEcCtD
Pimecrolimus—Pneumonia—Risedronate—Paget's disease of bone	0.00509	0.00522	CcSEcCtD
Pimecrolimus—Infestation NOS—Risedronate—Paget's disease of bone	0.00506	0.00519	CcSEcCtD
Pimecrolimus—Infestation—Risedronate—Paget's disease of bone	0.00506	0.00519	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00502	0.00515	CcSEcCtD
Pimecrolimus—Erythema—Alendronate—Paget's disease of bone	0.00493	0.00506	CcSEcCtD
Pimecrolimus—Influenza—Zoledronate—Paget's disease of bone	0.00493	0.00506	CcSEcCtD
Pimecrolimus—Asthma—Zoledronate—Paget's disease of bone	0.00493	0.00506	CcSEcCtD
Pimecrolimus—Arthralgia—Etidronic acid—Paget's disease of bone	0.00493	0.00505	CcSEcCtD
Pimecrolimus—Conjunctivitis—Risedronate—Paget's disease of bone	0.00492	0.00505	CcSEcCtD
Pimecrolimus—Pneumonia—Pamidronate—Paget's disease of bone	0.00484	0.00497	CcSEcCtD
Pimecrolimus—Infestation NOS—Pamidronate—Paget's disease of bone	0.00481	0.00494	CcSEcCtD
Pimecrolimus—Infestation—Pamidronate—Paget's disease of bone	0.00481	0.00494	CcSEcCtD
Pimecrolimus—Sinusitis—Risedronate—Paget's disease of bone	0.00475	0.00487	CcSEcCtD
Pimecrolimus—Infection—Etidronic acid—Paget's disease of bone	0.00469	0.00481	CcSEcCtD
Pimecrolimus—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00468	0.0048	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00458	0.0047	CcSEcCtD
Pimecrolimus—Rhinitis—Risedronate—Paget's disease of bone	0.00456	0.00467	CcSEcCtD
Pimecrolimus—Sinusitis—Pamidronate—Paget's disease of bone	0.00452	0.00463	CcSEcCtD
Pimecrolimus—Pharyngitis—Risedronate—Paget's disease of bone	0.00451	0.00463	CcSEcCtD
Pimecrolimus—Angioedema—Alendronate—Paget's disease of bone	0.00451	0.00462	CcSEcCtD
Pimecrolimus—Infestation—Zoledronate—Paget's disease of bone	0.0044	0.00451	CcSEcCtD
Pimecrolimus—Infestation NOS—Zoledronate—Paget's disease of bone	0.0044	0.00451	CcSEcCtD
Pimecrolimus—Rhinitis—Pamidronate—Paget's disease of bone	0.00433	0.00444	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.0043	0.00441	CcSEcCtD
Pimecrolimus—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00427	0.00438	CcSEcCtD
Pimecrolimus—Eye disorder—Risedronate—Paget's disease of bone	0.00425	0.00436	CcSEcCtD
Pimecrolimus—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00424	0.00435	CcSEcCtD
Pimecrolimus—Immune system disorder—Risedronate—Paget's disease of bone	0.00411	0.00421	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Risedronate—Paget's disease of bone	0.0041	0.0042	CcSEcCtD
Pimecrolimus—Constipation—Etidronic acid—Paget's disease of bone	0.00404	0.00414	CcSEcCtD
Pimecrolimus—Eye disorder—Pamidronate—Paget's disease of bone	0.00404	0.00414	CcSEcCtD
Pimecrolimus—Flushing—Pamidronate—Paget's disease of bone	0.00401	0.00411	CcSEcCtD
Pimecrolimus—Infection—Alendronate—Paget's disease of bone	0.004	0.0041	CcSEcCtD
Pimecrolimus—Malnutrition—Risedronate—Paget's disease of bone	0.00396	0.00406	CcSEcCtD
Pimecrolimus—Immune system disorder—Pamidronate—Paget's disease of bone	0.0039	0.004	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00389	0.00399	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00386	0.00396	CcSEcCtD
Pimecrolimus—Back pain—Risedronate—Paget's disease of bone	0.00383	0.00393	CcSEcCtD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.0038	0.152	CbGpPWpGaD
Pimecrolimus—Erythema—Pamidronate—Paget's disease of bone	0.00376	0.00386	CcSEcCtD
Pimecrolimus—Malnutrition—Pamidronate—Paget's disease of bone	0.00376	0.00386	CcSEcCtD
Pimecrolimus—Urticaria—Etidronic acid—Paget's disease of bone	0.00375	0.00385	CcSEcCtD
Pimecrolimus—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00373	0.00383	CcSEcCtD
Pimecrolimus—Eye disorder—Zoledronate—Paget's disease of bone	0.00369	0.00378	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00367	0.00376	CcSEcCtD
Pimecrolimus—Flushing—Zoledronate—Paget's disease of bone	0.00366	0.00376	CcSEcCtD
Pimecrolimus—Back pain—Pamidronate—Paget's disease of bone	0.00364	0.00373	CcSEcCtD
Pimecrolimus—Angioedema—Risedronate—Paget's disease of bone	0.00362	0.00371	CcSEcCtD
Pimecrolimus—Immune system disorder—Zoledronate—Paget's disease of bone	0.00356	0.00366	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00356	0.00365	CcSEcCtD
Pimecrolimus—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00348	0.00357	CcSEcCtD
Pimecrolimus—Cough—Risedronate—Paget's disease of bone	0.00345	0.00354	CcSEcCtD
Pimecrolimus—Pain—Alendronate—Paget's disease of bone	0.00344	0.00353	CcSEcCtD
Pimecrolimus—Constipation—Alendronate—Paget's disease of bone	0.00344	0.00353	CcSEcCtD
Pimecrolimus—Angioedema—Pamidronate—Paget's disease of bone	0.00344	0.00353	CcSEcCtD
Pimecrolimus—Erythema—Zoledronate—Paget's disease of bone	0.00344	0.00352	CcSEcCtD
Pimecrolimus—Malnutrition—Zoledronate—Paget's disease of bone	0.00344	0.00352	CcSEcCtD
Pimecrolimus—Arthralgia—Risedronate—Paget's disease of bone	0.00337	0.00346	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00335	0.00343	CcSEcCtD
Pimecrolimus—Pruritus—Etidronic acid—Paget's disease of bone	0.00334	0.00343	CcSEcCtD
Pimecrolimus—Back pain—Zoledronate—Paget's disease of bone	0.00332	0.00341	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00329	0.00338	CcSEcCtD
Pimecrolimus—Cough—Pamidronate—Paget's disease of bone	0.00328	0.00337	CcSEcCtD
Pimecrolimus—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00323	0.00331	CcSEcCtD
Pimecrolimus—Infection—Risedronate—Paget's disease of bone	0.00321	0.00329	CcSEcCtD
Pimecrolimus—Arthralgia—Pamidronate—Paget's disease of bone	0.0032	0.00328	CcSEcCtD
Pimecrolimus—Urticaria—Alendronate—Paget's disease of bone	0.0032	0.00328	CcSEcCtD
Pimecrolimus—Body temperature increased—Alendronate—Paget's disease of bone	0.00318	0.00326	CcSEcCtD
Pimecrolimus—Abdominal pain—Alendronate—Paget's disease of bone	0.00318	0.00326	CcSEcCtD
Pimecrolimus—Nervous system disorder—Risedronate—Paget's disease of bone	0.00317	0.00325	CcSEcCtD
Pimecrolimus—Angioedema—Zoledronate—Paget's disease of bone	0.00314	0.00322	CcSEcCtD
Pimecrolimus—Skin disorder—Risedronate—Paget's disease of bone	0.00314	0.00322	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00307	0.00315	CcSEcCtD
Pimecrolimus—Oedema—Pamidronate—Paget's disease of bone	0.00307	0.00315	CcSEcCtD
Pimecrolimus—Infection—Pamidronate—Paget's disease of bone	0.00305	0.00313	CcSEcCtD
Pimecrolimus—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00301	0.00309	CcSEcCtD
Pimecrolimus—Vomiting—Etidronic acid—Paget's disease of bone	0.003	0.00308	CcSEcCtD
Pimecrolimus—Cough—Zoledronate—Paget's disease of bone	0.003	0.00308	CcSEcCtD
Pimecrolimus—Rash—Etidronic acid—Paget's disease of bone	0.00298	0.00305	CcSEcCtD
Pimecrolimus—Dermatitis—Etidronic acid—Paget's disease of bone	0.00298	0.00305	CcSEcCtD
Pimecrolimus—Hypersensitivity—Alendronate—Paget's disease of bone	0.00297	0.00304	CcSEcCtD
Pimecrolimus—Headache—Etidronic acid—Paget's disease of bone	0.00296	0.00303	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00294	0.00302	CcSEcCtD
Pimecrolimus—MTOR—Cellular response to heat stress—VCP—Paget's disease of bone	0.00293	0.117	CbGpPWpGaD
Pimecrolimus—Arthralgia—Zoledronate—Paget's disease of bone	0.00293	0.003	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.0029	0.00298	CcSEcCtD
Pimecrolimus—Paraesthesia—Risedronate—Paget's disease of bone	0.0029	0.00297	CcSEcCtD
Pimecrolimus—Dyspnoea—Risedronate—Paget's disease of bone	0.00288	0.00295	CcSEcCtD
Pimecrolimus—Pruritus—Alendronate—Paget's disease of bone	0.00285	0.00292	CcSEcCtD
Pimecrolimus—Nausea—Etidronic acid—Paget's disease of bone	0.00281	0.00288	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.0028	0.00288	CcSEcCtD
Pimecrolimus—Oedema—Zoledronate—Paget's disease of bone	0.0028	0.00288	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.0028	0.00287	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00279	0.00286	CcSEcCtD
Pimecrolimus—Infection—Zoledronate—Paget's disease of bone	0.00279	0.00286	CcSEcCtD
Pimecrolimus—Pain—Risedronate—Paget's disease of bone	0.00276	0.00283	CcSEcCtD
Pimecrolimus—Constipation—Risedronate—Paget's disease of bone	0.00276	0.00283	CcSEcCtD
Pimecrolimus—Paraesthesia—Pamidronate—Paget's disease of bone	0.00276	0.00283	CcSEcCtD
Pimecrolimus—Diarrhoea—Alendronate—Paget's disease of bone	0.00275	0.00282	CcSEcCtD
Pimecrolimus—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00275	0.00282	CcSEcCtD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—PML—Paget's disease of bone	0.00274	0.11	CbGpPWpGaD
Pimecrolimus—Dyspnoea—Pamidronate—Paget's disease of bone	0.00274	0.00281	CcSEcCtD
Pimecrolimus—Skin disorder—Zoledronate—Paget's disease of bone	0.00272	0.00279	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00265	0.00272	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00264	0.00271	CcSEcCtD
Pimecrolimus—Pain—Pamidronate—Paget's disease of bone	0.00263	0.00269	CcSEcCtD
Pimecrolimus—Constipation—Pamidronate—Paget's disease of bone	0.00263	0.00269	CcSEcCtD
Pimecrolimus—Urticaria—Risedronate—Paget's disease of bone	0.00257	0.00263	CcSEcCtD
Pimecrolimus—Vomiting—Alendronate—Paget's disease of bone	0.00256	0.00262	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00255	0.00262	CcSEcCtD
Pimecrolimus—Body temperature increased—Risedronate—Paget's disease of bone	0.00255	0.00262	CcSEcCtD
Pimecrolimus—Abdominal pain—Risedronate—Paget's disease of bone	0.00255	0.00262	CcSEcCtD
Pimecrolimus—Rash—Alendronate—Paget's disease of bone	0.00254	0.0026	CcSEcCtD
Pimecrolimus—Dermatitis—Alendronate—Paget's disease of bone	0.00254	0.0026	CcSEcCtD
Pimecrolimus—Headache—Alendronate—Paget's disease of bone	0.00252	0.00259	CcSEcCtD
Pimecrolimus—Paraesthesia—Zoledronate—Paget's disease of bone	0.00252	0.00258	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00251	0.00257	CcSEcCtD
Pimecrolimus—Dyspnoea—Zoledronate—Paget's disease of bone	0.0025	0.00256	CcSEcCtD
Pimecrolimus—Abdominal pain—Pamidronate—Paget's disease of bone	0.00243	0.00249	CcSEcCtD
Pimecrolimus—Body temperature increased—Pamidronate—Paget's disease of bone	0.00243	0.00249	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00242	0.00248	CcSEcCtD
Pimecrolimus—Pain—Zoledronate—Paget's disease of bone	0.0024	0.00246	CcSEcCtD
Pimecrolimus—Constipation—Zoledronate—Paget's disease of bone	0.0024	0.00246	CcSEcCtD
Pimecrolimus—Nausea—Alendronate—Paget's disease of bone	0.00239	0.00245	CcSEcCtD
Pimecrolimus—Hypersensitivity—Risedronate—Paget's disease of bone	0.00238	0.00244	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00229	0.00235	CcSEcCtD
Pimecrolimus—Pruritus—Risedronate—Paget's disease of bone	0.00228	0.00234	CcSEcCtD
Pimecrolimus—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00226	0.00232	CcSEcCtD
Pimecrolimus—Urticaria—Zoledronate—Paget's disease of bone	0.00223	0.00228	CcSEcCtD
Pimecrolimus—Body temperature increased—Zoledronate—Paget's disease of bone	0.00222	0.00227	CcSEcCtD
Pimecrolimus—Abdominal pain—Zoledronate—Paget's disease of bone	0.00222	0.00227	CcSEcCtD
Pimecrolimus—Diarrhoea—Risedronate—Paget's disease of bone	0.00221	0.00227	CcSEcCtD
Pimecrolimus—Pruritus—Pamidronate—Paget's disease of bone	0.00217	0.00223	CcSEcCtD
Pimecrolimus—Diarrhoea—Pamidronate—Paget's disease of bone	0.0021	0.00215	CcSEcCtD
Pimecrolimus—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00207	0.00212	CcSEcCtD
Pimecrolimus—Vomiting—Risedronate—Paget's disease of bone	0.00205	0.00211	CcSEcCtD
Pimecrolimus—Rash—Risedronate—Paget's disease of bone	0.00204	0.00209	CcSEcCtD
Pimecrolimus—Dermatitis—Risedronate—Paget's disease of bone	0.00203	0.00209	CcSEcCtD
Pimecrolimus—Headache—Risedronate—Paget's disease of bone	0.00202	0.00207	CcSEcCtD
Pimecrolimus—Pruritus—Zoledronate—Paget's disease of bone	0.00198	0.00203	CcSEcCtD
Pimecrolimus—Vomiting—Pamidronate—Paget's disease of bone	0.00195	0.002	CcSEcCtD
Pimecrolimus—Rash—Pamidronate—Paget's disease of bone	0.00194	0.00199	CcSEcCtD
Pimecrolimus—Dermatitis—Pamidronate—Paget's disease of bone	0.00193	0.00198	CcSEcCtD
Pimecrolimus—Headache—Pamidronate—Paget's disease of bone	0.00192	0.00197	CcSEcCtD
Pimecrolimus—Diarrhoea—Zoledronate—Paget's disease of bone	0.00192	0.00197	CcSEcCtD
Pimecrolimus—Nausea—Risedronate—Paget's disease of bone	0.00192	0.00197	CcSEcCtD
Pimecrolimus—Nausea—Pamidronate—Paget's disease of bone	0.00182	0.00187	CcSEcCtD
Pimecrolimus—Vomiting—Zoledronate—Paget's disease of bone	0.00178	0.00183	CcSEcCtD
Pimecrolimus—Rash—Zoledronate—Paget's disease of bone	0.00177	0.00181	CcSEcCtD
Pimecrolimus—Dermatitis—Zoledronate—Paget's disease of bone	0.00177	0.00181	CcSEcCtD
Pimecrolimus—Headache—Zoledronate—Paget's disease of bone	0.00176	0.0018	CcSEcCtD
Pimecrolimus—Nausea—Zoledronate—Paget's disease of bone	0.00167	0.00171	CcSEcCtD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00165	0.0661	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—INPP5D—Paget's disease of bone	0.00129	0.0517	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00128	0.051	CbGpPWpGaD
Pimecrolimus—MTOR—mTOR signaling pathway—PML—Paget's disease of bone	0.00127	0.0509	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—INPP5D—Paget's disease of bone	0.00105	0.0421	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00101	0.0405	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000969	0.0387	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.00076	0.0304	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000742	0.0297	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000657	0.0263	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—VCP—Paget's disease of bone	0.000622	0.0249	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.0006	0.024	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000591	0.0236	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000341	0.0136	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—VCP—Paget's disease of bone	0.000318	0.0127	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NUP205—Paget's disease of bone	0.000243	0.00972	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VCP—Paget's disease of bone	0.000223	0.00891	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000208	0.00833	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CALCA—Paget's disease of bone	0.000181	0.00722	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—VCP—Paget's disease of bone	0.000179	0.00716	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NUP205—Paget's disease of bone	0.000148	0.00592	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NUP205—Paget's disease of bone	0.000137	0.00547	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PML—Paget's disease of bone	0.000131	0.00524	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00013	0.00521	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CALCA—Paget's disease of bone	0.000126	0.00506	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—INPP5D—Paget's disease of bone	0.000126	0.00505	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VCP—Paget's disease of bone	0.000125	0.00501	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SQSTM1—Paget's disease of bone	0.000113	0.00453	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CALCA—Paget's disease of bone	0.000102	0.00406	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SQSTM1—Paget's disease of bone	7.33e-05	0.00293	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CALCA—Paget's disease of bone	7.11e-05	0.00284	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NUP205—Paget's disease of bone	3.04e-05	0.00121	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	2.59e-05	0.00104	CbGpPWpGaD
